埃洛比西巴特在患有慢性便秘的帕金森病中的有效性和安全性:CONST-PD研究
Taku Hatano1, Genko Oyama1, Yasushi Shimo2
1Department of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.
埃洛比克西巴特在治疗帕金森病 (PD) 患者的慢性便秘方面显示出潜力,改善了肠道排便频率和生活质量. 虽然它没有达到主要终点,但它为这种常见的PD并发症提供了治疗效益.
科学领域:
- 胃肠病学 胃肠病学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性便秘是帕金森病 (PD) 患者中普遍存在的胃肠道问题.
- 调查PD相关便秘的新疗法目标至关重要.
研究的目的:
- 评价伊利叶胆酸载体抑制剂 - - 伊利叶胆酸载体抑制剂 - - 伊利叶胆酸载体抑制剂在帕金森病患者慢性便秘治疗中的有效性.
- 评估埃米格西巴特对自发排便 (SBM) 频率,便一致性和生活质量 (QOL) 的影响.
主要方法:
- 一项为期4周的双盲,安慰剂控制的研究,涉及帕金森病和慢性便秘患者.
- 患者接受了10毫克的epipixibat或安慰剂,每天记录肠道运动日记和QOL评估.
- 第4周自发排便 (SBM) 频率作为主要终点.
主要成果:
- 与基线相比,Elobixibat显著增加了每周SBM频率 (p=0.0079),而安慰剂组没有显著变化.
- 主要终点 (SBM频率变化在第4周的组间差异) 不具有统计学意义 (p=0.2601).
- 便的一致性,治疗满意度和QOL分数在埃米格西巴特组的改善被观察到,没有新的安全问题.
结论:
- 埃洛比克西巴特在帕金森病患者的慢性便秘中对SBM频率和QOL参数产生了积极影响.
- 虽然初级终点没有达到,但epixabat显示为这个患者群体的治疗选择有前途.
- 进一步的研究可能会澄清 elobixibat 在管理与帕金森病相关的便秘中的作用.
更多相关视频
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
03:50Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
